Allianzgi Health Sciences Fund Manager Performance Evaluation

RAGHX Fund  USD 28.35  0.42  1.50%   
The fund shows a Beta (market volatility) of 0.14, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Allianzgi Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Allianzgi Health is expected to be smaller as well.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allianzgi Health Sciences has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's technical indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
...more
Expense Ratio Date6th of November 2020
Expense Ratio1.3800
  

Allianzgi Health Relative Risk vs. Return Landscape

If you would invest  3,057  in Allianzgi Health Sciences on August 24, 2024 and sell it today you would lose (222.00) from holding Allianzgi Health Sciences or give up 7.26% of portfolio value over 90 days. Allianzgi Health Sciences is currently producing negative expected returns and takes up 0.7599% volatility of returns over 90 trading days. Put another way, 6% of traded mutual funds are less volatile than ALLIANZGI, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Allianzgi Health is expected to under-perform the market. But the company apears to be less risky and when comparing its historical volatility, the company is 1.0 times less risky than the market. the firm trades about -0.15 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 of returns per unit of risk over similar time horizon.

Allianzgi Health Current Valuation

Fairly Valued
Today
28.35
Please note that Allianzgi Health's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Allianzgi Health Sciences shows a prevailing Real Value of $28.64 per share. The current price of the fund is $28.35. We determine the value of Allianzgi Health Sciences from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Allianzgi Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ALLIANZGI Mutual Fund. However, Allianzgi Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  28.35 Real  28.64 Hype  28.35 Naive  27.66
The intrinsic value of Allianzgi Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Allianzgi Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
28.64
Real Value
29.40
Upside
Estimating the potential upside or downside of Allianzgi Health Sciences helps investors to forecast how ALLIANZGI mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Allianzgi Health more accurately as focusing exclusively on Allianzgi Health's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
27.9529.1030.24
Details
Hype
Prediction
LowEstimatedHigh
27.5928.3529.11
Details
Naive
Forecast
LowNext ValueHigh
26.9027.6628.42
Details

Allianzgi Health Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Allianzgi Health's investment risk. Standard deviation is the most common way to measure market volatility of mutual funds, such as Allianzgi Health Sciences, and traders can use it to determine the average amount a Allianzgi Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1536

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsRAGHX

Estimated Market Risk

 0.76
  actual daily
6
94% of assets are more volatile

Expected Return

 -0.12
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.15
  actual daily
0
Most of other assets perform better
Based on monthly moving average Allianzgi Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Allianzgi Health by adding Allianzgi Health to a well-diversified portfolio.

Allianzgi Health Fundamentals Growth

ALLIANZGI Mutual Fund prices reflect investors' perceptions of the future prospects and financial health of Allianzgi Health, and Allianzgi Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ALLIANZGI Mutual Fund performance.

About Allianzgi Health Performance

Evaluating Allianzgi Health's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Allianzgi Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Allianzgi Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
The fund seeks to achieve its objective by normally investing at least 80 percent of its net assets in health sciences-related companies. The portfolio manager considers health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences. The fund will invest primarily in common stocks and other equity securities.

Things to note about Allianzgi Health Sciences performance evaluation

Checking the ongoing alerts about Allianzgi Health for important developments is a great way to find new opportunities for your next move. Mutual Fund alerts and notifications screener for Allianzgi Health Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Allianzgi Health generated a negative expected return over the last 90 days
The fund generated three year return of -2.0%
Allianzgi Health Sciences maintains 95.72% of its assets in stocks
Evaluating Allianzgi Health's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Allianzgi Health's mutual fund performance include:
  • Analyzing Allianzgi Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Allianzgi Health's stock is overvalued or undervalued compared to its peers.
  • Examining Allianzgi Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Allianzgi Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Allianzgi Health's management team can help you assess the Mutual Fund's leadership.
  • Pay attention to analyst opinions and ratings of Allianzgi Health's mutual fund. These opinions can provide insight into Allianzgi Health's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Allianzgi Health's mutual fund performance is not an exact science, and many factors can impact Allianzgi Health's mutual fund market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Other Information on Investing in ALLIANZGI Mutual Fund

Allianzgi Health financial ratios help investors to determine whether ALLIANZGI Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALLIANZGI with respect to the benefits of owning Allianzgi Health security.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets